Literature DB >> 8006004

A mutant of protein phosphatase-1 that exhibits altered toxin sensitivity.

Z Zhang1, S Zhao, F Long, L Zhang, G Bai, H Shima, M Nagao, E Y Lee.   

Abstract

A chimeric mutant was constructed in which a 4-amino acid region (GEFD, residues 274-277) of rabbit muscle protein phosphatase-1 was replaced with the sequence YRCG corresponding to residues 267-270 of rabbit protein phosphatase-2A. This was based on the findings of a gene mutation in okadaic acid-resistant cells which results in a Cys-->Gly conversion in protein phosphatase-2A. The YRCG mutant of protein phosphatase-1 was expressed and purified. The properties of the mutant enzyme were investigated in terms of its sensitivity toward several toxin inhibitors (okadaic acid, microcystin, nodularin, calyculin A, and cantharidic acid), as well as inhibitor-2. The mutant enzyme exhibited a gain of function in the form of a 10-fold increased sensitivity toward okadaic acid that suggests this region is involved in toxin binding. Significant changes in sensitivity to inhibitor-2 and several of the other toxins were also observed, indicating that these may have a common binding region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006004

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Protein phosphatase 1 regulation by inhibitors and targeting subunits.

Authors:  T Watanabe; H B Huang; A Horiuchi; E F da Cruze Silva; L Hsieh-Wilson; P B Allen; S Shenolikar; P Greengard; A C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding.

Authors:  H B Huang; A Horiuchi; J Goldberg; P Greengard; A C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Characterization of the interaction between DARPP-32 and protein phosphatase 1 (PP-1): DARPP-32 peptides antagonize the interaction of PP-1 with binding proteins.

Authors:  Y G Kwon; H B Huang; F Desdouits; J A Girault; P Greengard; A C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Multiple genes encoding serine/threonine protein phosphatases and their differential expression in Nicotiana tabacum.

Authors:  M C Suh; H S Cho; Y S Kim; J R Liu; H S Lee
Journal:  Plant Mol Biol       Date:  1998-01       Impact factor: 4.076

Review 5.  Serine/threonine protein phosphatases.

Authors:  S Wera; B A Hemmings
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

6.  Effects of modification of the hydrophobic C-1-C-16 segment of tautomycin on its affinity to type-1 and type-2A protein phosphatases.

Authors:  A Takai; K Tsuboi; M Koyasu; M Isobe
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

7.  Regulation of Saccharomyces cerevisiae kinetochores by the type 1 phosphatase Glc7p.

Authors:  I Sassoon; F F Severin; P D Andrews; M R Taba; K B Kaplan; A J Ashford; M J Stark; P K Sorger; A A Hyman
Journal:  Genes Dev       Date:  1999-03-01       Impact factor: 11.361

8.  Dictyostelium discoideum protein phosphatase-1 catalytic subunit exhibits distinct biochemical properties.

Authors:  Luiz P M Andrioli; Paulo A Zaini; Wladia Viviani; Aline M Da Silva
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Characterization of the PP2A alpha gene mutation in okadaic acid-resistant variants of CHO-K1 cells.

Authors:  H Shima; H Tohda; S Aonuma; M Nakayasu; A A DePaoli-Roach; T Sugimura; M Nagao
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

Review 10.  Viewing serine/threonine protein phosphatases through the eyes of drug designers.

Authors:  Mengmeng Zhang; S D Yogesha; Joshua E Mayfield; Gordon N Gill; Yan Zhang
Journal:  FEBS J       Date:  2013-09-05       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.